$AGIO AGIOS PHARMACEUTICALS, INC. Insider Trading Week 39/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. in week 39/2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 2,500 | 756 | 778,320 | |
| Oct 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 60.07 | 6,500 | 390,455 | 131,272 | 137.8 K to 131.3 K (-4.72 %) |
| Oct 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 60.07 | 6,500 | 390,455 | 249,272 | 255.8 K to 249.3 K (-2.54 %) |
| Oct 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 2,500 | 756 | 255,772 | 253.3 K to 255.8 K (+0.99 %) |
| Oct 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Sell | S | 60.07 | 13,000 | 780,910 | 156,835 | 169.8 K to 156.8 K (-7.65 %) |
| Oct 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 4,500 | 2,104 | 261,317 | |
| Oct 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 60.07 | 4,500 | 270,315 | 35,000 | 39.5 K to 35 K (-11.39 %) |
| Oct 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 4,500 | 2,104 | 39,500 | 35 K to 39.5 K (+12.86 %) |
| Oct 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 9.05 | 1,500 | 13,575 | 110,498 | |
| Oct 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Sell | S | 60.07 | 1,500 | 90,105 | 0 | 1.5 K to 0 (-100.00 %) |
| Oct 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 9.05 | 1,500 | 13,575 | 1,500 | 0 to 1.5 K |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 9.05 | 7,548 | 68,309 | 111,998 | |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 2.34 | 9,725 | 22,757 | 119,546 | |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 0.69 | 227 | 156 | 129,271 | |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Sell | S | 56.53 | 17,500 | 989,275 | 0 | 17.5 K to 0 (-100.00 %) |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 9.05 | 7,548 | 68,309 | 17,500 | 10 K to 17.5 K (+75.84 %) |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 2.34 | 9,725 | 22,757 | 9,952 | 227 to 10 K (+4,284.14 %) |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 0.69 | 227 | 156 | 227 | 0 to 227 |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 30,000 | 9,075 | 780,820 | |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 62.68 | 30,000 | 1,880,400 | 137,772 | 167.8 K to 137.8 K (-17.88 %) |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 62.68 | 30,000 | 1,880,400 | 253,272 | 283.3 K to 253.3 K (-10.59 %) |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 30,000 | 9,075 | 283,272 | 253.3 K to 283.3 K (+11.84 %) |